MolPort-001-792-501

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

52 API Suppliers, 8 USDMF, 7 CEP/COS, 13 JDMF, 5 EU WC, 6 KDMF, 8 NDC API, 33 Listed Suppliers

DEVELOPMENTS

13 Drug(s) in Development

13 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

DOSSIERs // Finished Dosage Formulations

261 Dossiers, 19 FDA Orange Book, 45 Europe, 9 Canada, 63 South Africa, 125 Listed Dossiers

DRUG PRODUCT COMPOSITION

FOR SOLUTION;INTRAVENOUS - 80MG/VIAL;0.02MG/VIAL;0.001MG/VIAL;5MG/VIAL;0.01MG/VIAL;0.14MG/VIAL;17MG/VIAL;0.2MG/VIAL;1MG/VIAL;1.4MG/VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/VIAL, SOLUTION;INTRAVENOUS - 25,000MG/50ML (500MG/ML), SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML, SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML, INJECTABLE;INTRAVENOUS - 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL, INJECTABLE;INJECTION - 20MG/ML;0.006MG/ML;0.05MCG/ML;1.5MG/ML;0.0005MG/ML;0.06MG/ML;4MG/ML;0.6MG/ML;0.36MG/ML;0.6MG/ML;0.1MG/ML;1MG/ML

FOR SOLUTION;INTRAVENOUS - 80MG/VIAL;0.02MG/VIAL;0.001MG/VIAL;5MG/VIAL;0.01MG/VIAL;0.14MG/VIAL;17MG/VIAL;0.2MG/VIAL;1MG/VIAL;1.4MG/VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/VIAL
SOLUTION;INTRAVENOUS - 25,000MG/50ML (500MG/ML)
SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML
SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML
INJECTABLE;INTRAVENOUS - 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL
INJECTABLE;INJECTION - 20MG/ML;0.006MG/ML;0.05MCG/ML;1.5MG/ML;0.0005MG/ML;0.06MG/ML;4MG/ML;0.6MG/ML;0.36MG/ML;0.6MG/ML;0.1MG/ML;1MG/ML

RELATED EXCIPIENT COMPANIES

Suppliers, 39 Roquette, 36 BASF, 34 Kerry, 22 SPI Pharma, 22 Microlex e.U, 16 Actylis, 16 Seppic, 14 Rochem International Inc, 13 Gangwal Chemicals, 13 Corel Pharma Chem, 12 Gangwal Healthcare, 12 Nanjing Well Pharmaceutical, 11 Sigachi Industries, 10 DKSH, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 7 Ideal Cures Pvt Ltd, 7 Boai NKY Pharmaceuticals Ltd, 6 Lonza Capsugel, 5 DFE Pharma, 5 Kima Chemical, 4 The Dow Chemical Company, 4 Vasa Pharmachem, 4 ACG Worldwide, 4 Ingredion Pharma Solutions, 3 Ulanqab Kema New Material, 3 Shijiazhuang Huaxu Pharmaceutical, 3 Doshion Polyscience, 3 Pharmatrans-Sanaq, 3 Prachin Chemical, 2 Nomisma Healthcare, 2 Seqens, 2 Zhejiang Huakang Pharmaceutical, 2 Finar, 2 Kewpie Corporation, 2 Clariant, 2 Aeon Procare, 2 Jai Radhe Sales, 2 Evonik, 2 Bioplus Life Sciences, 2 Pharm-RX Chemical, 2 Qualicaps, 2 Pfanstiehl, 1 Avesta Pharma, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Alcedo Pharmachem, 1 Nanjing Bold Chemical

EXCIPIENTS BY APPLICATIONS

103 Fillers, Diluents & Binders, 61 Coating Systems & Additives, 48 Direct Compression, 44 Taste Masking, 41 Solubilizers, 39 Controlled & Modified Release, 36 Parenteral, 36 Disintegrants & Superdisintegrants, 35 Thickeners and Stabilizers, 31 Granulation, 28 Topical, 27 Film Formers & Plasticizers, 24 Lubricants & Glidants, 23 Chewable & Orodispersible Aids, 17 Co-Processed Excipients, 13 Emulsifying Agents, 11 API Stability Enhancers, 9 Empty Capsules, 7 Rheology Modifiers, 5 Surfactant & Foaming Agents, 4 Vegetarian Capsules, 2 Coloring Agents, 1 Soft Gelatin

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 18 Finished Drug Prices

MARKET PLACE

168 APIs, 34 DOSSIERS // FDF, 12 EXCIPIENTS, 1 CONTRACT SERVICES

PATENTS

12 US Patents, 1 US Exclusivities

ANALYTICAL SOLUTION(s)

11 Analytical Solutions, 5 EDQM Standards, 2 USP Standards, 3 JP Standards, 6 Other Ref. Standards

DIGITAL CONTENT

24 News

24 News

Full Screen View

FDA warns that Tydemy, a oral contraceptive, may have reduced effectiveness

FDA

02 Aug 2023

Enforcement Report - Week of June 14, 2023

FDA

14 Jun 2023

Enforcement Report - Week Of June 01, 2022

FDA

01 Jun 2022

Enforcement Report - Week of December 08, 2021

FDA

08 Dec 2021

Health Canada Recalls CellChem Pharmaceuticals' Hot Lemon Relief For Symptoms of Cold and Flu (Acetaminophen 650mg, Phenylephrine Hydrochloride 10mg, Ascorbic Acid 50mg, Pheniramine Maleate 20mg)

HEALTH CANADA

22 Nov 2021

KRS Global Biotechnology Issues Voluntary Nationwide Recall of All Human and Animal Sterile Drug Products

FDA

14 Sep 2019

Enforcement Report - Week of August 14, 2019

FDA

14 Aug 2019

From Celin to Septran, GSK Pharma sold 8-10 tail-end brands in FY19

BUSINESS STANDARD

16 Jul 2019

Breakthrough study of the effect of antioxidants and vitamin C on the skin

BUSINESSWIRE

09 May 2019

Enforcement Report for Week of February 20, 2019

FDA

20 Feb 2019

FDA Confirms Paragraph IV Patent Challenge of Plenvu 209381 (Polyethylene Glycol 3350 For Oral Solution)

FDA

13 Feb 2019

FDA alerts Not to use Promise Pharmacy's drugs intended to be sterile

FDA

07 Dec 2018

Enforcement Report - Week of November 7, 2018

FDA

07 Nov 2018

Enforcement Report - Week of August 15, 2018

FDA

15 Aug 2018

BMS looks to sell French OTC drug unit valued at $1.8B: report

Angus Liu FIERCE PHARMA

07 Jul 2018

Enforcement Report - Week of April 25, 2018

FDA

25 Apr 2018

Enforcement Report - Week of February 14, 2018

FDA

14 Feb 2018

Made in the USA' lawsuit against CVS Health is dismissed

Jonathan Stempel REUTERS

15 Feb 2017

US FDA Enforcement Report- 8/June/2016

FDA

08 Jun 2016

Dolvinol – news in JGL’s portfolio of non-prescription drugs

PRESS RELEASE

27 Apr 2016

GSK Nigeria, SBF resume talks on new acquisition deal

Femi Adekoya THE GUARDIAN

27 Jan 2016

Health in a Heartbeat

Press Release USANA HEALTH SCIENCES

23 Feb 2015

$Pharmacy Creations, Ongoing Class I recall of Ascorbic Acid 500 mg/mL Sterile Injection, 50mL Multi-dose Vial, Rx only, Pharmacy Creations, Randolph, NJ 07869 (973) 328-8756. because of Non-Sterility: Failing sterility results were obtained from the recalling firm\'s contract testing facility indicating that the products may not be sterile.$

Pharmacy Creations, Ongoing Class I recall of Ascorbic Acid 500 mg/mL Sterile Injection, 50mL Multi-dose Vial, Rx only, Pharmacy Creations, Randolph, NJ 07869 (973) 328-8756. because of Non-Sterility: Failing sterility results were obtained from the recalling firm's contract testing facility indicating that the products may not be sterile.

Http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0305-2015&w=12312014&lang=eng

31 Dec 2014

Government Caps Prices of 52 More Essential Drugs, Including Painkillers & Antibiotics

Press Release THE ECONOMIC TIMES

11 Dec 2014

Find Radio Compass News for MolPort-001-792-501

MolPort-001-792-501

MolPort-001-792-501

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

52 API Suppliers

8 USDMF

7 CEP/COS

13 JDMF

5 EU WC

6 KDMF

8 NDC API

33 Listed Suppliers

DEVELOPMENTS

13 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

DOSSIERs // Finished Dosage Formulations

261 Dossiers

19 FDA Orange Book

45 Europe

9 Canada

63 South Africa

125 Listed Dossiers

DRUG PRODUCT COMPOSITION

FOR SOLUTION;INTRAVENOUS - 80MG/VIAL;0.02MG/VIAL;0.001MG/VIAL;5MG/VIAL;0.01MG/VIAL;0.14MG/VIAL;17MG/VIAL;0.2MG/VIAL;1MG/VIAL;1.4MG/VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/VIAL

SOLUTION;INTRAVENOUS - 25,000MG/50ML (500MG/ML)

SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML

SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML

INJECTABLE;INTRAVENOUS - 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL

INJECTABLE;INJECTION - 20MG/ML;0.006MG/ML;0.05MCG/ML;1.5MG/ML;0.0005MG/ML;0.06MG/ML;4MG/ML;0.6MG/ML;0.36MG/ML;0.6MG/ML;0.1MG/ML;1MG/ML

RELATED EXCIPIENT COMPANIES

Suppliers

39 Roquette

36 BASF

34 Kerry

22 SPI Pharma

22 Microlex e.U

16 Actylis

16 Seppic

14 Rochem International Inc

13 Gangwal Chemicals

13 Corel Pharma Chem

12 Gangwal Healthcare

12 Nanjing Well Pharmaceutical

11 Sigachi Industries

10 DKSH

9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

7 Ideal Cures Pvt Ltd

7 Boai NKY Pharmaceuticals Ltd

6 Lonza Capsugel

5 DFE Pharma

5 Kima Chemical

4 The Dow Chemical Company

4 Vasa Pharmachem

4 ACG Worldwide

4 Ingredion Pharma Solutions

3 Ulanqab Kema New Material

3 Shijiazhuang Huaxu Pharmaceutical

3 Doshion Polyscience

3 Pharmatrans-Sanaq

3 Prachin Chemical

2 Nomisma Healthcare

2 Seqens

2 Zhejiang Huakang Pharmaceutical

2 Finar

2 Kewpie Corporation

2 Clariant

2 Aeon Procare

2 Jai Radhe Sales

2 Evonik

2 Bioplus Life Sciences

2 Pharm-RX Chemical

2 Qualicaps